Shagun Singh Chadha
Stock Analyst at RBC Capital
(0.89)
# 3,821
Out of 5,005 analysts
665
Total ratings
45.4%
Success rate
-1%
Average return
Main Sectors:
Stocks Rated by Shagun Singh Chadha
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Reiterated: Buy | $420 | $275.31 | +52.56% | 49 | Sep 16, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $110 | $86.83 | +26.68% | 54 | Jul 23, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $130 | $100.98 | +28.74% | 44 | Jul 16, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $600 → $575 | $414.79 | +38.62% | 48 | Jul 16, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Hold | $175 | $183.83 | -4.80% | 12 | Jul 13, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $100 → $85 | $44.11 | +92.70% | 57 | Jul 13, 2026 | |
| DXCM DexCom | Reiterated: Buy | $85 | $86.68 | -1.94% | 28 | Jul 13, 2026 | |
| GEHC GE HealthCare Technologies | Reiterated: Buy | $80 | $66.78 | +19.80% | 2 | Jul 13, 2026 | |
| GMED Globus Medical | Reiterated: Buy | $120 → $115 | $74.78 | +53.78% | 40 | Jul 13, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $45 | $70.00 | -35.71% | 28 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $287 | $271.95 | +5.53% | 46 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $89.50 | +31.84% | 47 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $2.96 | +136.49% | 40 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $374 | $319.18 | +17.18% | 39 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $245 | $133.11 | +84.06% | 18 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $155 | $127.38 | +21.68% | 51 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $16.42 | +82.70% | 20 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $91.62 | +10.24% | 41 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $74 | $16.27 | n/a | 1 | Apr 29, 2021 |
Stryker
Sep 16, 2026
Reiterated: Buy
Price Target: $420
Current: $275.31
Upside: +52.56%
Edwards Lifesciences
Jul 23, 2026
Reiterated: Buy
Price Target: $110
Current: $86.83
Upside: +26.68%
Abbott Laboratories
Jul 16, 2026
Reiterated: Buy
Price Target: $130
Current: $100.98
Upside: +28.74%
Intuitive Surgical
Jul 16, 2026
Reiterated: Buy
Price Target: $600 → $575
Current: $414.79
Upside: +38.62%
Becton, Dickinson and Company
Jul 13, 2026
Reiterated: Hold
Price Target: $175
Current: $183.83
Upside: -4.80%
Boston Scientific
Jul 13, 2026
Reiterated: Buy
Price Target: $100 → $85
Current: $44.11
Upside: +92.70%
DexCom
Jul 13, 2026
Reiterated: Buy
Price Target: $85
Current: $86.68
Upside: -1.94%
GE HealthCare Technologies
Jul 13, 2026
Reiterated: Buy
Price Target: $80
Current: $66.78
Upside: +19.80%
Globus Medical
Jul 13, 2026
Reiterated: Buy
Price Target: $120 → $115
Current: $74.78
Upside: +53.78%
Inspire Medical Systems
Jul 13, 2026
Reiterated: Hold
Price Target: $45
Current: $70.00
Upside: -35.71%
Jul 13, 2026
Reiterated: Buy
Price Target: $265 → $287
Current: $271.95
Upside: +5.53%
Jul 13, 2026
Reiterated: Buy
Price Target: $118
Current: $89.50
Upside: +31.84%
Jul 13, 2026
Reiterated: Hold
Price Target: $7
Current: $2.96
Upside: +136.49%
Jul 13, 2026
Reiterated: Hold
Price Target: $374
Current: $319.18
Upside: +17.18%
Jul 13, 2026
Reiterated: Buy
Price Target: $280 → $245
Current: $133.11
Upside: +84.06%
Jul 13, 2026
Reiterated: Buy
Price Target: $155
Current: $127.38
Upside: +21.68%
Jul 13, 2026
Reiterated: Buy
Price Target: $30
Current: $16.42
Upside: +82.70%
Jul 13, 2026
Reiterated: Buy
Price Target: $101
Current: $91.62
Upside: +10.24%
Apr 29, 2021
Reiterated: Hold
Price Target: $74
Current: $16.27
Upside: n/a